Oxford Asset Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-444,687
| Closed | -$1.87M | – | 2148 |
|
|
2018
Q4 | $1.87M | Buy |
+444,687
| New | +$1.87M | 0.05% | 506 |
|
|
2017
Q2 | – | Sell |
-456,033
| Closed | -$4.31M | – | 1787 |
|
|
2017
Q1 | $4.31M | Buy |
456,033
+180,618
| +66% | +$1.71M | 0.1% | 186 |
|
|
2016
Q4 | $2.38M | Buy |
+275,415
| New | +$2.38M | 0.08% | 273 |
|
|
2015
Q4 | – | Sell |
-382,027
| Closed | -$2.19M | – | 991 |
|
|
2015
Q3 | $2.19M | Sell |
382,027
-781,581
| -67% | -$4.47M | 0.07% | 276 |
|
|
2015
Q2 | $8.68M | Buy |
1,163,608
+558,564
| +92% | +$4.17M | 0.24% | 97 |
|
|
2015
Q1 | $3.62M | Sell |
605,044
-498,804
| -45% | -$2.98M | 0.09% | 247 |
|
|
2014
Q4 | $8.35M | Buy |
1,103,848
+1,006,591
| +1,035% | +$7.62M | 0.18% | 103 |
|
|
2014
Q3 | $511K | Buy |
+97,257
| New | +$511K | 0.01% | 549 |
|
|
2014
Q2 | – | Sell |
-101,275
| Closed | -$414K | – | 815 |
|
|
2014
Q1 | $414K | Buy |
+101,275
| New | +$414K | 0.01% | 536 |
|
|
2013
Q4 | – | Sell |
-127,856
| Closed | -$643K | – | 834 |
|
|
2013
Q3 | $643K | Buy |
+127,856
| New | +$643K | 0.01% | 629 |
|